Research & Development
19 September 2017 - - US-based biopharmaceutical company Symbiomix Therapeutics has received US Food and Drug Administration (FDA) approval for Solosec (secnidazole) 2g oral granules for the treatment...
19 September 2017 - - Yardley, Pennsylvania-based otolaryngology and allergy therapeutics developer Optinose has received approval from the US Food and Drug Administration (FDA) of its New Drug Applic...
19 September 2017 - - South San Francisco, California-based biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), has provided positive results from the Phase ...
19 September 2017 - - Eden Prairie, Minnesota-based medical device and in vitro diagnostic technologies provider Surmodics, Inc. (NASDAQ: SRDX) has received US Food and Drug Administration (FDA) 510(k...
19 September 2017 - - Littleton, Massachusetts-based compact proton therapy solutions specialist Mevion Medical Systems has submitted its 510(k) Premarket Notification to the US Food and Drug Administ...
19 September 2017 - - Irvine, California-based noninvasive monitoring technologies specialist Masimo (NASDAQ: MASI) has received FDA 510(k) clearance and full market release of Rad-97 Pulse CO-Ox...
Related Headlines